FOREST LABORATORIES, LLC v. SIGMAPHARM LABORATORIES, LLC, decided March 14, 2019, Claim Interpretation

U.S. Patent No. 5,763,476 is directed to Saphris, an antipsychotic drug.  The limitation of claim 1 of “the composition is a solid composition and disintegrates within 30 seconds in water at 37 degrees C” was limited by the district court to sublingual or buccal formulations, which is a limitation of dependent claim 4 (pages 4-5).  […]